Biomanufacturing Site Coming To Alexandria s Watertown Campus The future site of a 40K SF biomanufacturing facility at Alexandria s The Arsenal on the Charles.
The region’s biggest life sciences players have teamed up to deliver a much-needed biomanufacturing facility just miles away from the market’s Kendall Square epicenter.
The Massachusetts Center for Advanced Biological Innovation and Manufacturing, called CABIM, has signed a 40K SF lease at The Arsenal on the Charles in Watertown with Alexandria Real Estate Equities, it announced Thursday. The upcoming biomanufacturing center is backed by $76M in financing in a round led by Harvard University, as well as the Massachusetts Institute of Technology, life sciences companies and area hospitals.
Fujifilm and the Center for Advanced Biological Innovation and Manufacturing Announce $76M in Funding for Manufacturing and Innovation Center
News provided by
Share this article
Share this article
TOKYO, Jan. 14, 2021 /PRNewswire/ FUJIFILM Corporation (COO: Kenji Sukeno) and the Center for Advanced Biological Innovation and Manufacturing (CABIM), today announced that it has secured $76 million in financing and signed a lease for a 40,000 square-foot site in Watertown, Massachusetts at
The Arsenal on the Charles, owned and operated by Alexandria Real Estate Equities, Inc. The Center will advance research and development in cell and gene therapy, gene editing, immunotherapy, and biotechnology. FUJIFILM Diosynth Biotechnologies, the Bio CDMO
The Massachusetts Center for Advanced Biological Innovation and Manufacturing has obtained $76 million in funding and signed a lease for a 40,000-square foot site in Watertown, Mass. for the manufacturing and innovation of new biotechnologies, it announced in a press release Thursday.
A public-private partnership led by Harvard and the Massachusetts Institute of Technology, CABIM was formed in late 2019 to foster partnerships between academics, biopharma, and medical leaders to accelerate the production and delivery of new treatment technologies to patients.
Harvard led the fundraising effort, along with other founding members of CABIM including MIT, FUJIFILM Diosynth Biotechnologies, Cytiva, and Alexandria Real Estate Equities, Inc., which owns and operates the business park where the center will be located, called The Arsenal on the Charles.
Alexandria Real Estate Equities (ARE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).